PSA (L106) Peptide 
Datasheet
COA
MSDS
SHIP
Product Name :
PSA (L106) Peptide Applications :
Blocking Background :
Prostate specific antigen (PSA), also designated γ-seminoprotein, seminin, p30 antigen, semenogelase and kallikrein 3 (KLK3), was first identified as a glycoprotein in human seminal plasma. PSA was determined by sequence similarity to be a member of the kallikrein subfamily of trypsin proteases. PSA is a serine protease that hydrolyzes the major human seminal protein, the seminal plasma mobility inhibitor precursor or semenogelin I (SPMIP or SgI), which leads to semen liquification. PSA production and expression are highest in normal, benign hyperplastic and cancerous tissues of the prostate, although PSA has also been detected in accessory male sex glands and in breast cancer. PSA has been identified as an aid in the early detection of prostate cancer and is a commonly used tumor marker. Alternative Name :
APS; Gamma seminoprotein; Gamma-seminoprotein; hK3; Kallikrein 3; Kallikrein related peptidase 3; Kallikrein-3; KLK 3; KLK2A1; KLK3; KLK3; P 30 antigen; P-30 antigen; P30 antigen; Prostate Specific Antigen; Prostate Specific Antigen; Prostate-specific antigen; Psa; Semenogelase; Seminin; Swiss-Prot :
P07288 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide PSA (L106). (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS1302 PSA (L106) pAb.
PSA (L106) Peptide Applications :
Blocking Background :
Prostate specific antigen (PSA), also designated γ-seminoprotein, seminin, p30 antigen, semenogelase and kallikrein 3 (KLK3), was first identified as a glycoprotein in human seminal plasma. PSA was determined by sequence similarity to be a member of the kallikrein subfamily of trypsin proteases. PSA is a serine protease that hydrolyzes the major human seminal protein, the seminal plasma mobility inhibitor precursor or semenogelin I (SPMIP or SgI), which leads to semen liquification. PSA production and expression are highest in normal, benign hyperplastic and cancerous tissues of the prostate, although PSA has also been detected in accessory male sex glands and in breast cancer. PSA has been identified as an aid in the early detection of prostate cancer and is a commonly used tumor marker. Alternative Name :
APS; Gamma seminoprotein; Gamma-seminoprotein; hK3; Kallikrein 3; Kallikrein related peptidase 3; Kallikrein-3; KLK 3; KLK2A1; KLK3; KLK3; P 30 antigen; P-30 antigen; P30 antigen; Prostate Specific Antigen; Prostate Specific Antigen; Prostate-specific antigen; Psa; Semenogelase; Seminin; Swiss-Prot :
P07288 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide PSA (L106). (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS1302 PSA (L106) pAb.
Blocking peptide available as BS1302PP